L’ORÉAL GROUPE PARTNERS WITH ABOLIS AND EVONIK TO SCALE DEVELOPMENT OF NEXT-GENERATION BIO-BASED INGREDIENTS
Tri-party agreement will drive biotech innovation via integrated lab-to-market collaboration
Clichy, September 12, 2024 -
L’Oréal
today announces a tri-party agreement with biotech innovator, Abolis
Biotechnologies
and global specialty...
Zur Pressemeldung auf www.loreal.com